Tenzing Acquisition Corp. (TZAC)
|Net Income (ttm)||-666,641|
|Trading Day||Dec 14, 2021|
|Day's Range||8.33 - 9.11|
|52-Week Range||8.33 - 11.88|
Reviva Pharmaceuticals, Inc. and Tenzing Acquisition Corp. Complete their Business Combination and Trade as Reviva Pharmaceuticals Holdings, Inc.
Combined Company to Trade on NASDAQ Post-closing under Tickers: RVPH and RVPHW
NEW YORK, Sept. 14, 2020 /PRNewswire/ -- Tenzing Acquisition Corp.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Tenzing Acquisition Corp. with Reviva Pharmaceuticals, Inc.
New York, New York--(Newsfile Corp. - July 24, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who own Tenzing Acquisition Corp.
Tenzing Acquisition does not have significant operations. It intends to acquire, engage in a share exchange, share reconstruction and amalgamation with, purchase all or substantially all of the assets of, enter into contractual arrangements with, or engage in any other similar business combination with one or more businesses or entities primarily operates in India. The company was founded in 2018 and is based in New York, New York.
|Stock Exchange |
|Ticker Symbol |